# Latent Toxoplasmosis in Females With Borderline Personality Disorder

> **NCT03932656** · — · WITHDRAWN · sponsor: **Marie Ociskova**

## Conditions studied

- Borderline Personality Disorder
- Toxoplasmosis

## Interventions

- **BEHAVIORAL:** Combined schema-therapy and cognitive behavioral therapy
- **DRUG:** Psychopharmaceuticals

## Key facts

- **NCT ID:** NCT03932656
- **Lead sponsor:** Marie Ociskova
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding issues
- **Last updated:** 2024-04-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932656, "Latent Toxoplasmosis in Females With Borderline Personality Disorder". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT03932656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*